Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.2.19 (
ubiquitin-protein ligase
)
799
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In eukaryotic cells an uncleavable ubiquitin moiety conjugated to the N-terminus of a protein signals the degradation of the fusion protein via the proteasome-dependent ubiquitin fusion degradation (UFD) pathway. In yeast the molecular mechanism of the UFD pathway has been well characterized. Recently the human E3
ubiquitin-protein ligase
TRIP12
was connected with the UFD pathway, but little is otherwise known about this system in mammalian cells. In the present work, we utilized high-throughput imaging on cells transfected with a targeted siRNA library to identify components involved in degradation of the UFD substrate Ub(G76V)-YFP. The most significant hits from the screen were the E3 ubiquitin-protein ligase HUWE1, as well as PSMD7 and PSMD14 that encode proteasome subunits. Accordingly, knock down of HUWE1 led to an increase in the steady state level and a retarded degradation of the UFD substrate. Knock down of HUWE1 also led to a stabilization of the physiological UFD substrate UBB(+1). Precipitation experiments revealed that HUWE1 is associated with both the Ub(G76V)-YFP substrate and the 26S proteasome, indicating that it functions late in the UFD pathway. Double knock down of HUWE1 and
TRIP12
resulted in an additive stabilization of the substrate, suggesting that HUWE1 and
TRIP12
function in parallel during UFD. However, even when both HUWE1 and
TRIP12
are downregulated, ubiquitylation of the UFD substrate was still apparent, revealing functional redundancy between HUWE1,
TRIP12
and yet other ubiquitin-protein ligases.
...
PMID:HUWE1 and TRIP12 collaborate in degradation of ubiquitin-fusion proteins and misframed ubiquitin. 2320 76
Pancreas transcription factor 1a (PTF1a) plays a crucial role in the early development of the pancreas and in the maintenance of the acinar cell phenotype. Several transcriptional mechanisms regulating expression of PTF1a have been identified. However, regulation of PTF1a protein stability and degradation is still unexplored. Here, we report that inhibition of proteasome leads to elevated levels of PTF1a and to the existence of polyubiquitinated forms of PTF1a. We used the Sos recruitment system, an alternative two-hybrid system method to detect protein-protein interactions in the cytoplasm and to map the interactome of PTF1a. We identified
TRIP12
(thyroid hormone receptor-interacting protein 12), an E3
ubiquitin-protein ligase
as a new partner of PTF1a. We confirmed PTF1a/
TRIP12
interaction in acinar cell lines and in co-transfected HEK-293T cells. The protein stability of PTF1a is significantly increased upon decreased expression of
TRIP12
. It is reduced upon overexpression of
TRIP12
but not a catalytically inactive
TRIP12
-C1959A mutant. We identified a region of
TRIP12
required for interaction and identified lysine 312 of PTF1a as essential for proteasomal degradation. We also demonstrate that
TRIP12
down-regulates PTF1a transcriptional and antiproliferative activities. Our data suggest that an increase in
TRIP12
expression can play a part in PTF1a down-regulation and indicate that PTF1a/
TRIP12
functional interaction may regulate pancreatic epithelial cell homeostasis.
...
PMID:The E3 ubiquitin ligase thyroid hormone receptor-interacting protein 12 targets pancreas transcription factor 1a for proteasomal degradation. 2535 11